Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | APP | P05067 | 2/20 | 0.45 |
| ▸ | ESRRG | P62508 | 1/20 | 0.44 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | DRD4 | P21917 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.43 |
| ▸ | MCHR1 | Q99705 | 3/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14173686 | 0.91 | NR1I2 (0.53) | MAPTL3MBTL1HPGDATMAPP | |
| SCHEMBL8943762 | 0.89 | MAPT (0.54) | MAPTL3MBTL1HPGDATMAPP | |
| SCHEMBL970989 | 0.89 | APP (0.53) | MAPTL3MBTL1HPGDATMAPP | |
| SCHEMBL8943807 | 0.87 | AHR (0.53) | MAPTL3MBTL1HPGDATMDRD2 | |
| SCHEMBL8944313 | 0.87 | AHR (0.53) | MAPTL3MBTL1HPGDATMDRD2 | |
| SCHEMBL13945546 | 0.86 | DRD2 (0.49) | MAPTL3MBTL1APPESRRGDRD2 | |
| SCHEMBL14174231 | 0.85 | APP (0.60) | L3MBTL1APPNR1I2TSHRSMN1; SMN2 | |
| SCHEMBL8944174 | 0.84 | NR5A1 (0.55) | MAPTL3MBTL1HPGDATMTDP1 | |
| SCHEMBL8944354 | 0.83 | TSHR (0.49) | MAPTL3MBTL1HPGDATMAPP | |
| SCHEMBL6977017 | 0.83 | MAPT (0.53) | MAPTL3MBTL1HPGDATMAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8846978-B2 | Electronic devices comprising novel phosphonic acid surface modifiers | IMPERIAL INNOVATIONS LTD. (GB) | 2014-09-30 | — | — | US | disclosed |
| US-8846978-B2 | Electronic devices comprising novel phosphonic acid surface modifiers | IMPERIAL INNOVATIONS LTD. (GB) | 2014-09-30 | — | — | US | disclosed |
| US-8586208-B2 | Stable electrodes with modified work functions and methods for organic electronic devices | GEORGIA TECH RESEARCH CORPORATION (US) | 2013-11-19 | — | — | US | disclosed |
| US-20120114974-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | NATIONAL SCIENCE FOUNDATION | 2012-05-10 | — | — | US | disclosed |
| EP-2417142-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | Georgia Tech Research Corporation (US) | 2012-02-15 | — | — | EP | disclosed |
| US-20110114935-A1 | Stable electrodes with modified work functions and methods for organic electronic devices | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-05-19 | — | — | US | disclosed |
| US-20110114935-A1 | Stable electrodes with modified work functions and methods for organic electronic devices | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-05-19 | — | — | US | disclosed |
| EP-2304820-A1 | STABLE ELECTRODES WITH MODIFIED WORK FUNCTIONS AND METHODS FOR ORGANIC ELECTRONIC DEVICES | Georgia Tech Research Corporation (US) | 2011-04-06 | — | — | EP | disclosed |
| WO-2010115854-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | GEORGIA TECH RESEARCH CORPORATION (US) | 2010-10-14 | — | — | WO | disclosed |
| WO-2010007081-A1 | STABLE ELECTRODES WITH MODIFIED WORK FUNCTIONS AND METHODS FOR ORGANIC ELECTRONIC DEVICES | GEORGIA TECH RESEARCH CORPORATION (US) | 2010-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110114935-A1 | Stable electrodes with modified work functions and methods for organic electronic devices | EPCAM, EMD, L1CAM | MAPT 2192/4885L3MBTL1 1096/4885HPGD 3483/4885 |
| US-20120114974-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | EFNA1, PHOSPHO1, EPHA6 | MAPT 3620/4885L3MBTL1 1793/4885HPGD 4387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.